ABSTRACT Background: Antioxidant-rich diets are associated with reduced asthma prevalence in epidemiologic studies. We previously showed that short-term manipulation of antioxidant defenses leads to changes in asthma outcomes. Objective: The objective was to investigate the effects of a highantioxidant compared with those of a low-antioxidant diet, with or without lycopene supplementation, in asthma. Design: Asthmatic adults (n = 137) were randomly assigned to a high-antioxidant diet (5 servings of vegetables and 2 servings of fruit daily; n = 46) or a low-antioxidant diet (#2 servings of vegetables and 1 serving of fruit daily; n = 91) for 14 d and then commenced a parallel, randomized, controlled supplementation trial. Subjects who consumed the high-antioxidant diet received placebo. Subjects who consumed the low-antioxidant diet received placebo or tomato extract (45 mg lycopene/d). The intervention continued until week 14 or until an exacerbation occurred. Results: After 14 d, subjects consuming the low-antioxidant diet had a lower percentage predicted forced expiratory volume in 1 s and percentage predicted forced vital capacity than did those consuming the high-antioxidant diet. Subjects in the low-antioxidant diet group had increased plasma C-reactive protein at week 14. At the end of the trial, time to exacerbation was greater in the highantioxidant than in the low-antioxidant diet group, and the lowantioxidant diet group was 2.26 (95% CI: 1.04, 4.91; P = 0.039) times as likely to exacerbate. Of the subjects in the low-antioxidant diet group, no difference in airway or systemic inflammation or clinical outcomes was observed between the groups that consumed the tomato extract and those who consumed placebo. Conclusions:Modifying the dietary intake of carotenoids alters clinical asthma outcomes. Improvements were evident only after increased fruit and vegetable intake, which suggests that whole-food interventions are most effective. This trial was registered at http:// www.actr.org.au as ACTRN012606000286549.
INTRODUCTION
Oxidative stress is important in the pathophysiology of asthma (1), contributing to airway smooth muscle contraction (2) , mucus hypersecretion (3), epithelial shedding (4), vascular exudation (5) , and induction of airway hyperresponsiveness (6) . Antioxidants protect against oxidative stress. These may be endogenous, including a range of antioxidant enzymes such as glutathione peroxidase and superoxide dismutase, or exogenous, such as vitamin C, vitamin E, carotenoids, and flavonoids, which are obtained from the diet, particularly from fruits and vegetables.
A large number of epidemiologic studies have reported that dietary antioxidants protect against the development of asthma or lung function decline. Fresh fruit intake is inversely associated with wheeze (7) and chronic lung disease onset (8) and is positively associated with the percentage predicted forced expiratory volume in 1 s (%FEV 1 ) 4 (9, 10) . Total fruit and vegetable intake is inversely related to asthma prevalence (11) but not to %FEV 1 (12) or airway obstruction (13) . Tomato products may protect against asthma onset (14) , and vegetables may protect against chronic bronchitis, asthma (15) , and wheeze (16) .
We have been investigating the role of carotenoids in asthma. These potent antioxidants are found primarily in fruit and vegetables. We observed that, despite normal dietary intake, peripheral blood concentrations of carotenoids, particularly lycopene, were low in asthmatic individuals (17) . We subsequently conducted a series of studies-by using in vitro, murine, and human modelsto examine the role of dietary antioxidants in protecting against common asthma triggers. In a murine model of allergic airway inflammation, we showed that lycopene supplementation reduces eosinophilic infiltrates in bronchoalveolar lavage fluid, lung tissue, blood, and mucus-secreting cell numbers in the airways, in response to an allergen challenge. Allergen-induced release of the T helper 2-associated cytokines IL-4 and IL-5 was also reduced (18) . In epithelial cell culture experiments, we showed that lycopene significantly decreased the production of IL-6 and interferon g-induced protein 10 after rhinovirus infection (19) .
We also showed that antioxidant manipulation modifies clinical asthma outcomes. As antioxidants were withdrawn from the diet, neutrophilic airway inflammation, lung function, and asthma symptoms worsened (20) . Conversely, short-term (7 d) consumption of lycopene-rich tomato products reversed this effect, by decreasing neutrophil influx and reducing sputum neutrophil elastase activity (20) . Also supporting a role for lycopene in asthma, short-term (7 d) supplementation with tomato extract reduced exercise-induced bronchoconstriction (21) . In this study, we aimed to extend our previous findings, hypothesizing that increasing antioxidant intake, via either increased consumption of fruit and vegetables or supplementation with tomato extract, would reduce inflammation and improve clinical outcomes in asthma.
SUBJECTS AND METHODS

Subjects
Adults with stable asthma (n = 137) were recruited from John Hunter Hospital Asthma Clinic, New South Wales, Australia, between July 2006 and March 2009. Asthma was diagnosed on the basis of current (past 12 mo) episodic respiratory symptoms, doctor's diagnosis of asthma, and airway hyperresponsiveness to hypertonic saline, defined as a fall in FEV 1 .15% from baseline. Clinical asthma pattern was categorized according to Global Initiative for Asthma guidelines (22) . Atopic status was determined by skin-prick allergy testing. Exclusion criteria included recent respiratory tract infection, asthma exacerbation or unstable asthma, or change in maintenance therapy, current smoking, and use of vitamin supplements. The study was approved by Hunter New England Health Human Research Ethics Committee, and subjects gave written informed consent.
Protocol
This was a parallel, randomized, controlled trial with 3 treatment arms: high-antioxidant (HAO) diet plus placebo (HAO group), low-antioxidant (LAO) diet plus tomato extract (LAOextract), and LAO diet plus placebo (LAO-placebo) ( Figure 1 ). Subjects were randomly allocated to 1 of the 3 treatment arms, determined by computer-generated random sequence, derived and held by an independent statistician. Initial group allocation was concealed from the clinical recruitment staff until each subject had entered the trial and received a randomization code. During the treatment phase, subjects were told that they were taking part in a study examining diet and asthma but were blinded to the hypothesis being tested, which avoided potential reporting bias. Clinical staff and investigators were blinded to the treatment received by those subjects on the LAO diet only.
After baseline data were collected, the subjects commenced a diet high or low in antioxidants for 14 d, according to their group allocation. After this run-in period, the HAO group and the LAO-placebo group commenced placebo capsules 3 times/d, and the LAO-extract group commenced tomato extract capsules 3 times/d. The subjects continued on the diet and capsules, with no change to their asthma medications, until an asthma exacerbation occurred. Asthma exacerbation was defined as an increased use of asthma medications, commencement of oral steroids, attendance to a doctor or hospital because of asthma, reduced activity because of asthma, or an increase in the validated Asthma Control Questionnaire (ACQ) .1 compared with baseline (23) . If an asthma exacerbation occurred, a final clinic visit was conducted and the subject exited the study. If a subject had not exacerbated within 14 wk, a final visit was scheduled. Clinic visits occurred at baseline; at weeks 2, 6, 10, and 14; and/or at the time of asthma exacerbation. The subjects fasted for 12 h before each visit. Spirometry, exhaled nitric oxide (NIOX; Aerocrine AB), the ACQ (23), plasma, and induced sputum were collected. Compliance with the dietary requirements and capsules was monitored by 24-h food recall at each visit and pill countback. Subjects who consumed ,80% of study capsules, subjects in the high-AO diet group who consumed ,5 servings fruit and vegetables/d, and subjects in the low-AO diet group who consumed .3 servings fruit and vegetables/d were deemed to be noncompliant and were excluded from the per-protocol analysis. Dietary requirements were met by 80% of subjects. Compliance with the capsules was met by 85% of subjects. No significant adverse events were reported during the study.
Participant flow
Subjects (n = 137) were recruited and at visit 1 were randomly assigned to the HAO (n = 46) or the LAO diet (n = 91) ( Figure 1 ). One hundred four subjects completed the initial 2-wk run-in period on the assigned diet, then at visit 2 commenced the supplementation phase; 40 of 104 subjects were allocated to the HAO group, 33 of 104 subjects were allocated to the LAO-extract group, and 31 of 104 subjects were allocated to the LAO-placebo group. The trial was completed by 79 of 104 subjects. The progress of subjects through the trial is described in Figure 1 .
Interventions
The LAO diet included #1 serving of fruit and 2 servings of vegetables daily, avoidance of foods containing antioxidant additives, and avoidance of other antioxidant-rich foods such as tea, coffee, red wine, fruit juices, nuts, and seeds (20) . The HAO diet included 5 servings of vegetables and 2 servings of fruit per day. The tomato extract capsules (Lyc-o-Mato; supplied by LycoRed Natural Products Industries, Ltd) contained 15 mg lycopene per capsule. One tomato extract capsule was taken 3 times/d and resulted in a total daily dose of 45 mg lycopene. The placebo was identical in appearance to the tomato extract capsules but contained only soybean oil, with one capsule taken 3 times/d.
Sputum induction and analysis
Spirometry (KoKo Spirometer; Pulmonary Data Service, Instrumentation Inc) and combined bronchial provocation and sputum induction with hypertonic saline (4.5%) were performed as described (24) by trained respiratory research officers. Lower respiratory sputum portions were selected from saliva and processed as described previously (24) . The dispersed suspension was filtered, and a total cell count of leukocytes and viability were performed. Cytospins were prepared and stained (May-Grünwald Giemsa), and a differential cell count was obtained from 400 nonsquamous cells. The remaining solution was centrifuged (400 3 g, 10 min, 4 8 C), and the cell-free supernatant fluid was aspirated and stored at -70 8 C.
Sputum supernatant fluid measurements
IL-8 concentrations were measured by ELISA (R&D Systems) with standard curves based on dilutions of purified recombinant IL-8. Neutrophil elastase activity was detected by using the Human Neutrophil Elastase Immunocapture Activity Assay Kit (Calbiochem). 8-Isoprostane concentrations were determined by ELISA (Cayman Chemicals). All fluid-phase mediators were previously validated for assessment in induced sputum (25, 26) .
Plasma inflammatory mediator analysis
Blood was collected into EDTA-containing tubes and centrifuged at 4 8 C and 3000 3 g for 10 min to separate plasma, which was stored at 280 8 C before analysis. Plasma IL-6 and TNF-a concentrations were analyzed by commercial ELISA (R&D Systems). C-reactive protein (CRP) concentrations were analyzed by commercial ELISA (MP-Biomedicals).
Carotenoid analysis
HPLC was used to measure plasma carotenoid concentrations, including lycopene, lutein, b-cryptoxanthin, a-carotene, and b-carotene (27) . All extractions were carried out in a darkened laboratory under red light. Ethanol:ethyl acetate (1:1) containing internal standards (canthaxanthin) and butylated hydroxyanisole was added to the sample. The solution was sonicated and centrifuged (3000 3 g, 4 8 C, 5 min), and the supernatant fluid was collected. This process was repeated 3 times, adding ethyl acetate twice then hexane to the pellet. Ultrapure water was then added to pooled supernatant fluid, and the mixture was vortex-mixed and centrifuged. The supernatant fluid was decanted, the solvents evaporated with nitrogen, and the sample reconstituted in dichloromethane:methanol (1:2, vol:vol). Chromatography was performed on a Hypersil ODS column (100 mm 3 2.1 mm 3 5 mm) with a flow rate of 0.3 mL/min. Carotenoids were quantified by calibrating with a standard (canthaxanthin) run over a range of known concentrations, under the same conditions. A mobile phase of acetonitrile:dichloromethane:methanol 0.05% ammonium acetate (85:10:5, vol:vol) was used. Carotenoids and tocopherols were detected at 470 and 290 nm, respectively, by using a photodiode array detector.
Statistical analysis
The primary outcome of this study was sputum %neutrophils (sputum neutrophil count expressed as a proportion of total sputum cells) after the 14-wk intervention. Other key outcomes of interest included ACQ, lung function, airway and systemic inflammatory markers, and time to asthma exacerbation. On the basis of our pilot study (20) , to have 80% power to detect the expected mean (6SD) change in sputum %neutrophils of 15 6 20 between the placebo and tomato extract groups, we required 29 subjects per group to complete the trial. The statistical analysis was performed by using SAS version 9.1. Group comparisons at baseline and day 14 were performed by using independent t tests or a Kruskal-Wallis test. Paired t tests or Mann-Whitney U tests were used to examine changes within groups at day 14 compared with baseline. Generalized linear mixed models (GLMMs) were used to determine the difference in changes during the supplementation phase (visits 2-5) between groups. GLMMs were adjusted for sex, age, and smoking history. Both the intention-to-treat analysis (with the last observation carried forward) and the per-protocol analysis were conducted and gave similar results. Initial GLMM analysis of the LAO-extract group compared with the LAO-placebo groups showed no statistical difference in clinical or inflammatory markers during the treatment phase. Hence, these groups were combined for further analysis of the effects of the HAO diet compared with those of the LAO-extract plus the LAO-placebo diets during the dietary intervention period (visits 1-5). To examine differences in time to exacerbation between groups, Kaplan-Meier curves were fitted and P values for the difference between groups were calculated by using the log-rank test. Cox proportional hazards modeling was used to examine differences in exacerbation hazard between groups after adjustment for sex, age, and smoking history. An additional analysis was undertaken in the LAO diet group by using Friedman's repeated-measures test with Dunn's post hoc testing to examine changes at each time point compared with baseline.
RESULTS
No differences in baseline characteristics were observed between subjects randomly assigned to the HAO group and those assigned to the LAO groups ( Table 1) . After 14 d of dietary modification, a significant decrease from baseline in plasma lycopene concentrations was observed in the LAO diet group, which was significantly different from the increase in the HAO diet group. In the HAO diet group, an increase was observed in other carotenoids, including lutein, b-cryptoxanthin, a-carotene, and b-carotene and a decrease in the LAO group such that the day 14 value for the HAO group was significantly greater than that for the LAO group ( Table 2) . A decrease from baseline in %FEV 1 and percentage predicted forced vital capacity (%FVC) was observed at day 14 compared with baseline in the LAO group, and these values were significantly different from those in the HAO diet group, in which no change between baseline and day 14 was observed ( Figure 2) .
Data presented in Tables 3 and 4 are from the intention-to-treat analysis. No differences in baseline characteristics were observed between subjects in the LAO-extract group and those in the LAOplacebo groups. After the supplementation phase, no differences in any key outcomes-including airway and systemic inflammation, lung function, and ACQ-were observed between the LAO-extract and LAO-placebo groups (Table 3) . Similarly, no differences in lung function or airway inflammation were observed throughout the supplementation phase between the HAO and LAO diet groups (Table 4) . However, repeated-measures analysis by time point showed that subjects in the LAO diet group had a significantly greater (P , 0.001) median plasma CRP concentration at the final visit In addition, there were significant differences in the time to exacerbation between the diet groups. The number of subjects 2 Group comparisons at baseline were performed by using independent t, Kruskal-Wallis, or Fisher exact tests. who experienced an exacerbation between baseline and week 14 was 9 of 46 (19.6%) in the HAO diet group compared with 25 of 91 (27.5%) in the LAO diet group. The increased risk of exacerbation in subjects in the LAO diet group is shown in Figure 4 .
With the use of the Cox proportional hazards model, with time to exacerbations as the outcome, and after adjustment for age, sex, and smoking history, subjects in the LAO diet group were 2.26 (95% CI: 1.04, 4.91) times as likely to have an exacerbation at any time compared with the HAO diet group (P = 0.039) ( Table 5 ). There was also a small, but statistically significant, decrease (P = 0.042) in ACQ in the HAO diet group compared with the LAO diet group (change in HAO diet group: 20.01; 95% CI: 20.03, 0.01 units) compared with the LAO diet group (0.00; 95% CI: 20.01, 0.01 units) ( Table 4) .
DISCUSSION
This was the first study to compare the effects of manipulating antioxidant concentrations in asthma by using LAO compared with HAO diets and a dietary supplement. We found that an LAO 1 Group comparisons at baseline and day 14 were performed by using independent t tests or a Kruskal-Wallis test. Paired t tests or Mann-Whitney U tests were used to examine changes within groups at day 14 compared with baseline. At baseline, there were no significant differences between the HAO and LAO groups. ACQ, Asthma Control Questionnaire; DRS, dose response slope (%fall in FEV 1 /mL saline); FEV 1 , forced expiratory volume in 1 s; HAO, high antioxidant; hsCRP, high-sensitivity C-reactive protein; LAO, low antioxidant; NE, neutrophil elastase; NO, nitric oxide; ppb, parts per billion; TCC, total cell count.
2 Median; interquartile range in parentheses (all such values).
3 Sputum eosinophil count expressed as a proportion of total sputum cells. 4 Significantly different from baseline, P , 0.05. 5 Sputum neutrophil count expressed as a proportion of total sputum cells. 6 Mean 6 SD (all such values). 7 P , 0.05 for the change between baseline and day 14 in HAO compared with LAO. 8 Significantly different from HAO on day 14, P , 0.05. 9 Includes lutein, b-cryptoxanthin, a-carotene, and b-carotene.
diet led to a reduction in lung function and an increased risk of asthma exacerbation compared with an HAO diet, associated with evidence of increased systemic inflammation. Among subjects in the LAO diet group, no difference in inflammation or clinical outcomes between the groups that consumed the antioxidant supplement compared with placebo was found. Whereas antioxidant supplements and dietary manipulation both increased antioxidant concentrations, clinical improvements were evident only after the HAO diet, which suggests that whole-food interventions are most effective. Despite the positive associations found in the epidemiologic data, there is limited direct evidence to support the use of antioxidant supplementation in asthma. To date, most of the supplementation trials in asthma have used isolated antioxidants, particularly vitamin C, with disappointing results (28, 29) . This has led to the suggestion that whole foods may be needed to improve nutritional status because of the interdependence of the nutrients that are naturally present in the wholefood matrix (28, 29) . In this study we showed that consumption of an LAO diet leads to an increased risk of asthma exacerbation. An increased risk of exacerbation, which is associated with a worsening of symptoms, is consistent with our previous observation that antioxidant withdrawal leads to a loss of asthma control (20) . In this study we also saw a small, but statistically significant, improvement in ACQ in subjects in the HAO diet group compared with the LAO diet group. To our knowledge, only one other study has monitored asthma as fruit consumption was increased. In a school program in the United Kingdom, children increased fruit intake from 1.3 to 2 servings/d, but asthma prevalence and severity did not change (30) . This intervention did not meet our definition of an HAO diet (ie, 7 servings of fruit and vegetables/d); hence, the lack of effect on asthma outcomes is not surprising. Another study in chronic obstructive pulmonary disease examined fruit and vegetable intake in a 3-y prospective study, with consumption increasing 1 All values are means (95% CIs). The data presented are from an intention-to-treat analysis, with the last observation carried forward. ACQ, Asthma Control Questionnaire; CRP, C-reactive protein; DRS, dose response slope (%fall in %FEV 1 /mL saline); LAO, low antioxidant; NE, neutrophil elastase; NO, nitric oxide; ppb, parts per billion; %FEV 1 , percentage predicted forced expiratory volume in 1 s; %FVC, percentage predicted forced vital capacity.
2 Generalized linear mixed models were used to determine the difference in changes during the supplementation phase (visits 2-5) between groups, which were adjusted for sex, age, and smoking history.
3 Sputum eosinophil count expressed as a proportion of total sputum cells. 4 Sputum neutrophil count expressed as a proportion of total sputum cells. from 3 to 5 servings/d, which was associated with a reduced annual rate of decline in %FEV 1 (31) . Changes in respiratory function occurred in our study in just 2 wk. After 2 wk of the LAO diet, lung function was reduced in comparison with baseline and with the HAO diet. This reproduces a key observation from our previous study, in which we observed changes in lung function of a similar size and magnitude in subjects who adopted an antioxidant-withdrawal diet (20) . Airway inflammation was monitored in this study, and we observed trends in sputum %neutrophils after antioxidant withdrawal, in line with our previous observations (20) . After 14 d of the LAO diet, there was a trend toward increased sputum %neutrophils, whereas in the HAO diet group there was a trend toward decreased sputum %neutrophils.
In this study, there was also a trend suggesting that an LAO diet worsened systemic inflammation after only 2 wk (Table 2 ; P = 0.063). Analysis by time point indicated that, by week 14, plasma CRP concentrations had increased significantly compared with baseline in the LAO diet group. Other researchers have also shown that fruit and vegetable intake can reduce systemic inflammation, specifically CRP concentrations (32, 33) . In addition, several cross-sectional studies of fruit and vegetable consumption have found an inverse association with CRP (34) (35) (36) . The clinical relevance of systemic inflammation in asthma is not well understood. However, it was previously reported that circulating CRP concentrations are elevated in neutrophilic (37) and nonallergic (38) asthmatics and steroid-naive asthma (39) and are correlated with lung function and airway inflammation (39) . Hence, interventions that modify systemic inflammation may hold promise as potential asthma-treatment strategies.
Whereas our study showed that withdrawal of antioxidant-rich foods from the diet modified systemic inflammation, 8-isoprostane-a marker of oxidative stress-did not change during the intervention. This suggests that the dietary modifications we introduced may be acting on nonredox-sensitive inflammatory pathways. As an antioxidant, lycopene is able to modify inflammatory responses by inhibiting production of cytokines, such as IL-6 and TNF-a (40), via nuclear factor-kB suppression (41) . In addition, lycopene has a broad range of other immunomodulatory 2 Generalized linear mixed models were used to determine the difference in changes during the dietary intervention phase (visits 1-5) between groups, which were adjusted for sex, age, and smoking history.
3 Sputum eosinophil count expressed as a proportion of total sputum cells. 4 Sputum neutrophil count expressed as a proportion of total sputum cells. effects, which lead to modulation of cellular functions such as gap junction communication (42) , growth factor signaling (43) , and upregulation of cell surface adhesion molecule gene expression (44) and detoxification enzymes (45) . Further investigation of the mechanisms behind our observations is warranted.
Interestingly, the HAO and LAO diets used in this study are very relevant to Western populations. The composition of the HAO diet, which consisted of 5 servings of vegetables and 2 servings of fruit daily, is equivalent to that currently recommended for adults in both Australia (46) and the United States (47) . Conversely, the LAO diet, which incorporated one serving of fruit and 2 servings of vegetables daily, represents the usual dietary intake in Western countries and is equivalent to the median intake for adult Australian males (all ages) and females (,45 y) (48) . Hence, this study indicates the potential for typical Western dietary patterns to contribute to a worsening of lung function and asthma control.
Whereas several clinical and biochemical outcomes have been shown to be modified by manipulating dietary antioxidant intake, we did not observe an effect of the lycopene-rich supplement compared with placebo. This raises questions about the generalizability of the results from our previous trial (20) , because we previously observed that this supplement reduced neutrophilic inflammation. Although the same supplementation dose was used in both studies, the increase in plasma lycopene was more modest in the current study. Previously, we observed a 7-fold increase after 7 d of supplementation. In the current study, baseline lycopene concentrations were similar, but only a 3.5-fold increase occurred. One possible explanation is reduced compliance because of the longer study duration. However, pill countback indicated compliance of w85%. Further investigation of interindividual responses to lycopene supplementation over time is warranted. Because of a higher than expected dropout rate (36%), the power to detect a significant difference in sputum %neutrophils was reduced to 70%. However, no trend in the data suggests that the lack of effect was the result of the study being underpowered.
We observed that manipulating dietary patterns, by changing the intake of antioxidant-rich foods, is more effective at improving asthma outcomes than is using a nutrient supplement. This may provide an explanation for the inconsistency in antioxidant supplementation trials in asthma to date. Vitamin C has been shown to reduce asthma exacerbation severity and frequency (49) and protect against airway hyperresponsiveness in some (50-52), but not other (53, 54) , trials. Selenium supplementation led to an improvement in a composite measure of lung function and airway hyperresponsiveness (55) . Yet, vitamin E supplementation in asthma showed no benefit (56) . Our data suggest that this heterogeneity may be attributed to the use of isolated nutrients. Dietary modifications using whole-food interventions containing antioxidants in their natural matrix are most likely to provide beneficial and safe treatment of asthma.
In conclusion, we showed that modifying dietary antioxidant consumption alters clinical asthma outcomes. Both antioxidant supplements and increased fruit and vegetable intake are effective methods for increasing carotenoid concentrations. However, clinical improvements are evident only as a result of an increased fruit and vegetable intake. The results provide further evidence that whole-food approaches should be used to achieve maximum efficacy of antioxidant interventions. 1 Kaplan-Meier curves were fitted to examine differences in time to exacerbation between groups, and P values for the difference between groups were calculated by using the log-rank test. Cox proportional hazards modeling was used to examine differences in exacerbation hazard between groups after adjustment for sex, age, and smoking history. . Kaplan-Meier survival curve for time to exacerbation in subjects consuming different study diets. Kaplan-Meier curves were fitted, and P values for the difference between groups were calculated by using the log-rank test. *P , 0.05 for the low-AO (n = 91) and high-AO (n = 46) diet groups. AO, antioxidant.
